As part of CINTESIS, the research group PharmaHTA is committed to therapeutics, pharmacovigilance and hypertension diagnosis.

The team of researchers studies the epidemiology, detection, collection and assessment of the adverse reactions caused by drugs in the population in general, and in the elderly in particular. The objective is to understand better the safety profile of drugs currently available in the market, and in the same line, contribute to the implementation of clinical trials, namely in the field of cardiovascular diseases.